exemestane

Italy

Drugs containing this active substance

  • AROMASIN

    It is used for the treatment of early-stage hormone-dependent breast cancer in postmenopausal women who have completed 2-3 years of tamoxifen therapy, and for the treatment of advanced hormone-dependent breast cancer in postmenopausal women when hormone therapy with another medicine has not been sufficient.

    Form: tablets, film-coated

    Active substance Dosage
    exemestane -

    ATC: L02BG06

    Manufacturer: PFIZER ITALIA S.R.L.

  • AXELTA

    It is used for the treatment of postmenopausal women with early-stage hormone-dependent breast cancer (after completing tamoxifen therapy for 2-3 years) or advanced-stage cancer, when hormone therapy with other anti-estrogenic medicines has not been effective.

    Form: tablets, film-coated

    Active substance Dosage
    exemestane -

    ATC: L02BG06

    Manufacturer: ISTITUTO GENTILI S.R.L.

  • EXEMESTANE AUROBINDO ITALIA

    It is used for the treatment of hormone-dependent breast cancer in postmenopausal women. Specifically, it is used for early-stage cancer (after 2-3 years of tamoxifen therapy) or for advanced-stage cancer when other hormonal therapies have not been sufficient.

    Form: tablets, film-coated

    Active substance Dosage
    exemestane -

    ATC: L02BG06

    Manufacturer: Eugia Pharma (Malta) Limited

  • EXEMESTANE DOC GENERICI

    It is used to treat hormone-dependent breast cancer in postmenopausal women. It can be used in the early stage (after 2-3 years of treatment with tamoxifen) or in the advanced stage, when other hormonal treatments have not been sufficient.

    Form: tablets, film-coated

    Active substance Dosage
    exemestane -

    ATC: L02BG06

    Manufacturer: DOC GENERICI SRL

  • EXEMESTANE MYLAN GENERICS

    It is used for the treatment of early-stage hormone-dependent breast cancer in postmenopausal women who have completed 2-3 years of tamoxifen therapy, and for the treatment of advanced hormone-dependent breast cancer in postmenopausal women when hormone therapy with another medicinal product has not been sufficiently effective.

    Form: tablets, film-coated

    Active substance Dosage
    exemestane -

    ATC: L02BG06

    Manufacturer: MYLAN S.P.A.

  • EXEMESTANE SANDOZ

    It is used to treat early-stage hormone-dependent breast cancer in postmenopausal women who have completed 2-3 years of treatment with tamoxifen. It is also indicated for the treatment of advanced hormone-dependent breast cancer in postmenopausal women when other hormonal treatments have not worked.

    Form: tablets, film-coated

    Active substance Dosage
    exemestane -

    ATC: L02BG06

    Manufacturer: SANDOZ S.P.A.

  • EXEMESTANE TEVA

    It is used to treat hormone-dependent breast cancer in postmenopausal women. It can be used for both early-stage cancer (after a period of treatment with tamoxifen) and advanced-stage cancer, if other hormonal treatments have not been effective.

    Form: tablets, film-coated

    Active substance Dosage
    exemestane -

    ATC: L02BG06

    Manufacturer: TEVA ITALIA S.R.L.

  • EXEMESTANE ZENTIVA

    This medicine is used to treat hormone-dependent breast cancer in postmenopausal women, both in the early stage (after 2-3 years of treatment with tamoxifen) and in the advanced stage (when other hormonal treatments have not been sufficient).

    Form: tablets, film-coated

    Active substance Dosage
    exemestane -

    ATC: L02BG06

    Manufacturer: ZENTIVA ITALIA S.R.L.

  • MESTANE

    It is used for the treatment of hormone-dependent breast cancer in postmenopausal women, both in the early stage (after 2-3 years of tamoxifen therapy) and in the advanced stage when other hormonal therapies have not been effective.

    Form: tablets, film-coated

    Active substance Dosage
    exemestane -

    ATC: L02BG06

    Manufacturer: SOPHOS BIOTECH S.R.L.

  • MEXABREST

    This medicine is used to treat early breast cancer in postmenopausal women who have already completed 2-3 years of treatment with tamoxifen. It is also indicated for the treatment of advanced stage breast cancer in postmenopausal women, when other hormonal treatments have not been sufficiently effective.

    Form: tablets, film-coated

    Active substance Dosage
    exemestane -

    ATC: L02BG06

    Manufacturer: ACCORD HEALTHCARE, S.L.U.

  • NIBESTAN

    This medicine is used for the treatment of hormone-dependent breast cancer in postmenopausal women. It may be prescribed after initial therapy with tamoxifen (for 2-3 years) or in cases of advanced-stage cancer where other treatments have not been effective.

    Form: tablets, film-coated

    Active substance Dosage
    exemestane -

    ATC: L02BG06

    Manufacturer: WAVE PHARMA S.R.L.

  • STANEXAM

    It is used to treat hormone-dependent breast cancer in postmenopausal women who have completed 2-3 years of treatment with tamoxifen, or for advanced breast cancer in postmenopausal women when other hormonal treatments have not been sufficient.

    Form: tablets, film-coated

    Active substance Dosage
    exemestane -

    ATC: L02BG06

    Manufacturer: ELLEVA PHARMA SRL

  • XELAMIN

    It is used for the treatment of early-stage hormone-dependent breast cancer in postmenopausal women who have completed 2-3 years of tamoxifen therapy, and for the treatment of advanced hormone-dependent breast cancer in postmenopausal women when hormone therapy with another medicine has not worked well enough.

    Form: tablets, film-coated

    Active substance Dosage
    exemestane -

    ATC: L02BG06

    Manufacturer: LANOVA FARMACEUTICI S.R.L.